TY - JOUR
T1 - Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens
T2 - An in vivo microdialysis study with cocaine
AU - Navailles, Sylvia
AU - Moison, Delphine
AU - Cunningham, Kathryn A.
AU - Spampinato, Umberto
N1 - Funding Information:
This work was supported by grants from the National Institute on Drug Abuse DA 00260, DA 020087, and DA13595 (KAC) and Center National de la Recherche Scientifique and Bordeaux 2 University. S Navailles was a fellowship recipient from the Ministère de la Recherche et de l’Enseignement Supérieur during the course of this study. We are grateful to Dr P Weber (F Hoffmann-La Roche, Basel, Switzerland) for the gift of Ro 60-0175.
PY - 2008/1
Y1 - 2008/1
N2 - Stimulation of central serotonin2C receptor (5-HT2CR) inhibits dopamine (DA)-dependent neurochemical and behavioral effects of cocaine, while 5-HT2CRs locally expressed into the ventral tegmental area (VTA) and the nucleus accumbens (NAc) exert opposite functional control over cocaine-induced behavioral effects. Using in vivo microdialysis in halothane-anesthetized rats, we tested the hypothesis that this functionally opposite regulation of the mesoaccumbens DA pathway relies on the ability of 5-HT2CRs in the VTA and the NAc to inhibit and enhance respectively cocaine-induced accumbal DA outflow. Intra-VTA injection of the 5-HT 2CR agonist Ro 60-0175 at 5 μg/0.2 μl, but not 1 μg/0.2 μl, attenuated the increase in accumbal DA outflow induced by the systemic administration of 10 mg/kg of cocaine. Intra-VTA injection of the 5-HT 2CR antagonist SB 242084 at either dose (0.1 or 0.5 μg/0.2 μl) did not modify the effects of cocaine. Intra-NAc application of Ro 60-0175 dose-dependently excited (0.1 μM) and inhibited (1 μM) cocaine-induced DA outflow. In contrast, intra-NAc application of SB 242084 resulted in diametrically opposite effects when applied at these concentrations. These results further support the idea that the overall action of central 5-HT 2CRs on accumbal DA output is dependent, at least in part, on the functional balance between different 5-HT2CR populations within the NAc and within the mesoaccumbens DA pathway (VTA vs NAc).
AB - Stimulation of central serotonin2C receptor (5-HT2CR) inhibits dopamine (DA)-dependent neurochemical and behavioral effects of cocaine, while 5-HT2CRs locally expressed into the ventral tegmental area (VTA) and the nucleus accumbens (NAc) exert opposite functional control over cocaine-induced behavioral effects. Using in vivo microdialysis in halothane-anesthetized rats, we tested the hypothesis that this functionally opposite regulation of the mesoaccumbens DA pathway relies on the ability of 5-HT2CRs in the VTA and the NAc to inhibit and enhance respectively cocaine-induced accumbal DA outflow. Intra-VTA injection of the 5-HT 2CR agonist Ro 60-0175 at 5 μg/0.2 μl, but not 1 μg/0.2 μl, attenuated the increase in accumbal DA outflow induced by the systemic administration of 10 mg/kg of cocaine. Intra-VTA injection of the 5-HT 2CR antagonist SB 242084 at either dose (0.1 or 0.5 μg/0.2 μl) did not modify the effects of cocaine. Intra-NAc application of Ro 60-0175 dose-dependently excited (0.1 μM) and inhibited (1 μM) cocaine-induced DA outflow. In contrast, intra-NAc application of SB 242084 resulted in diametrically opposite effects when applied at these concentrations. These results further support the idea that the overall action of central 5-HT 2CRs on accumbal DA output is dependent, at least in part, on the functional balance between different 5-HT2CR populations within the NAc and within the mesoaccumbens DA pathway (VTA vs NAc).
KW - 5-HT receptor
KW - Accumbal dopamine release
KW - Cocaine
KW - Nucleus accumbens
KW - Rat
KW - Ventral tegmental area
UR - http://www.scopus.com/inward/record.url?scp=36949016219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=36949016219&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1301414
DO - 10.1038/sj.npp.1301414
M3 - Article
C2 - 17429406
AN - SCOPUS:36949016219
SN - 0893-133X
VL - 33
SP - 237
EP - 246
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 2
ER -